Tag: ADX-102

May 17, 2017

Aldeyra Therapeutics Reveals Results from ADX-102 Trial

Aldeyra Therapeutics presented the results from their Phase 2 clinical trial of ADX-102 at this years' meeting of the Association...
April 27, 2017

Aldeyra Gets First Patient Enrolled in Phase 3 Trial

Aldeyra Therapeutics enrolled the first patient in their Phase 3 clinical trial of ADX-102.
April 20, 2017

Aldeyra Gets Orphan Drug Designation for ADX-102

Aldeyra Therapeutics received an orphan drug designation by the US Food and Drug Administration for ADX-102 in treating rare disease...
April 18, 2017

Aldeyra Doses Last Patient in Allergic Conjunctivitis Trial

Aldeyra Therapeutics announced the last patient dosing for its Phase 2b clinical trial of ADX-102 in allergic conjunctivitis.